You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Modeled ICURs for the UK (discounted, 3.5 %)

From: Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom

Outcomes, 3.5 % discount Mean value (95 % CI)
UK1
Cost per case averted £282 (118; 538)
Cost per GP visit averted £1,100 (456; 2,113)
Cost per ER visit averted £35,568 (14,729; 68,327)
Cost per hospitalization averted £23,929 (9,934; 45,494)
Cost per death averted £117,428 (43,067; 246,342)
Cost per QALY gained £7,989 (3,132; 16,318)
Cost per LY gained £11,081 (4,135; 23,186)
UK2
Cost per case averted £250 (105; 461)
Cost per GP visit averted £979 (404; 1,821)
Cost per ER visit averted £31,641 (13,069; 58,892)
Cost per hospitalization averted £21,207 (8,909; 39,220)
Cost per death averted £110,496 (42,719; 221,654)
Cost per QALY gained £7,324 (2,937; 14,044)
Cost per LY gained £10,364 (4,029; 20,588)
  1. Note: GP, general practitioner; ER, emergency room; QALY, quality-adjusted life year; LY, life year